Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-065539
Date:2021-11-18
Issuer: SORRENTO THERAPEUTICS, INC. (SRNE)
Original Submission Date:

Reporting Person:

CZEREPAK ELIZABETH
C/O SORRENTO THERAPEUTICS, INC.
4955 DIRECTORS PLACE SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.01 2021-11-18 deemed execution date A 100,000 (a) 2031-11-18 common stock 100,000 $6.01 100,000 direct
Footnotes
IDfootnote
f1 1/12th of the original number of shares subject to the option shall vest on december 18, 2021, and 1/12th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the reporting person's continued service to the issuer through each such vesting date.

Elevate your investments